{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:45:25Z","timestamp":1792608325276,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.alit.2021.07.007","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T09:44:47Z","timestamp":1629279887000},"page":"407-414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Hyper-IgE syndrome, 2021 update"],"prefix":"10.1016","volume":"70","author":[{"given":"Yoshiyuki","family":"Minegishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2021.07.007_bib1","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(66)90119-X","article-title":"Job's Syndrome. Recurrent, \"cold\", staphylococcal abscesses","volume":"1","author":"Davis","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2021.07.007_bib2","first-page":"169","article-title":"Physicochemical properties of reaginic antibody. 1. Association of reaginic activity with an immunoglobulin other than gammaA- or gammaG-globulin","volume":"37","author":"Ishizaka","year":"1966","journal-title":"J\u00a0Allergy"},{"key":"10.1016\/j.alit.2021.07.007_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1542\/peds.49.1.59","article-title":"Extreme hyperimmunoglobulinemia E and undue susceptibility to infection","volume":"49","author":"Buckley","year":"1972","journal-title":"Pediatrics"},{"key":"10.1016\/j.alit.2021.07.007_bib4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM199903043400904","article-title":"Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder","volume":"340","author":"Grimbacher","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2021.07.007_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-3476(03)00449-9","article-title":"Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity","volume":"144","author":"Renner","year":"2004","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.alit.2021.07.007_bib6","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1056\/NEJMoa0905506","article-title":"Combined immunodeficiency associated with DOCK8 mutations","volume":"361","author":"Zhang","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2021.07.007_bib7","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.alit.2021.07.007_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1385\/CRIAI:20:1:139","article-title":"The hyper-IgE syndrome","volume":"20","author":"Buckley","year":"2001","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.alit.2021.07.007_bib9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.0105-2896.2005.00228.x","article-title":"Hyper-IgE syndromes","volume":"203","author":"Grimbacher","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.alit.2021.07.007_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.coi.2009.07.013","article-title":"Hyper-IgE syndrome","volume":"21","author":"Minegishi","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.alit.2021.07.007_bib11","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s10875-021-01051-1","article-title":"STAT3 Hyper-IgE syndrome - an update and unanswered questions","volume":"41","author":"Tsilifis","year":"2021","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.alit.2021.07.007_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.alit.2021.07.007_bib13","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s10875-021-00980-1","article-title":"The ever-increasing array of novel inborn errors of immunity: an interim update by the IUIS Committee","volume":"41","author":"Tangye","year":"2021","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.alit.2021.07.007_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaci.2014.02.025","article-title":"Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels","volume":"133","author":"Sassi","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.07.007_bib15","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jaci.2014.02.013","article-title":"Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment","volume":"133","author":"Zhang","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.07.007_bib16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/377591a0","article-title":"Cytokine receptor signaling","volume":"377","author":"Ihle","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.alit.2021.07.007_bib17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.bi.64.070195.003201","article-title":"Transcriptional responses to polypeptide ligands: the JAK-STAT pathway","volume":"64","author":"Schindler","year":"1995","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.alit.2021.07.007_bib18","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1073\/pnas.94.8.3801","article-title":"Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality","volume":"94","author":"Takeda","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.alit.2021.07.007_bib19","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1038\/sj.onc.1203478","article-title":"Roles of STAT3 defined by tissue-specific gene targeting","volume":"19","author":"Akira","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.alit.2021.07.007_bib20","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/0091-6749(88)90873-1","article-title":"Impaired antibody responses in the hyperimmunoglobulin E syndrome","volume":"81","author":"Leung","year":"1988","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.07.007_bib21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0091-6749(91)90126-9","article-title":"Antibody responses to protein, polysaccharide, and phi X174 antigens in the hyperimmunoglobulinemia E (hyper-IgE) syndrome","volume":"87","author":"Sheerin","year":"1991","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.07.007_bib22","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","article-title":"Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey","volume":"91","author":"Chandesris","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.alit.2021.07.007_bib23","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jaip.2017.06.041","article-title":"Autosomal dominant hyper-IgE syndrome in the USIDNET registry","volume":"6","author":"Gernez","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2021.07.007_bib24","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/ctr.12834","article-title":"Adverse effects of voriconazole: over a decade of use","volume":"30","author":"Levine","year":"2016","journal-title":"Clin Transpl"},{"key":"10.1016\/j.alit.2021.07.007_bib25","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jaip.2019.01.033","article-title":"Severe necrotic reaction to 23-valent polysaccharide pneumococcal vaccine in a patient with STAT3 deficiency","volume":"7","author":"Pinones","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2021.07.007_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat4956","article-title":"A\u00a0recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity","volume":"3","author":"Beziat","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.alit.2021.07.007_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat4941","article-title":"ZNF341 controls STAT3 expression and thereby immunocompetence","volume":"3","author":"Frey-Jakobs","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.alit.2021.07.007_bib28","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.26058.1","article-title":"Interleukin-6 signaling in health and disease","volume":"9","author":"Rose-John","year":"2020","journal-title":"F1000Res"},{"key":"10.1016\/j.alit.2021.07.007_bib29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.93.1.407","article-title":"Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders","volume":"93","author":"Yoshida","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.alit.2021.07.007_bib30","doi-asserted-by":"crossref","first-page":"e20191306","DOI":"10.1084\/jem.20191306","article-title":"Absence of GP130 cytokine receptor signaling causes extended Stuve-Wiedemann syndrome","volume":"217","author":"Chen","year":"2020","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.alit.2021.07.007_bib31","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1084\/jem.20161810","article-title":"A\u00a0biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis","volume":"214","author":"Schwerd","year":"2017","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.alit.2021.07.007_bib32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3324\/haematol.2018.194233","article-title":"Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function","volume":"104","author":"Shahin","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.alit.2021.07.007_bib33","doi-asserted-by":"crossref","first-page":"e20191804","DOI":"10.1084\/jem.20191804","article-title":"Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome","volume":"217","author":"Beziat","year":"2020","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.alit.2021.07.007_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ajhg.2011.05.024","article-title":"Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth","volume":"89","author":"Nieminen","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.alit.2021.07.007_bib35","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1084\/jem.20190344","article-title":"Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses","volume":"216","author":"Spencer","year":"2019","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.alit.2021.07.007_bib36","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1084\/jem.20191002","article-title":"The nature of human IL-6","volume":"216","author":"Puel","year":"2019","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.alit.2021.07.007_bib37","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.immuni.2006.09.009","article-title":"Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity","volume":"25","author":"Minegishi","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.alit.2021.07.007_bib38","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1084\/jem.20140280","article-title":"Human TYK2 deficiency: mycobacterial and viral infections without hyper-IgE syndrome","volume":"212","author":"Kreins","year":"2015","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.alit.2021.07.007_bib39","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1002\/eji.201646519","article-title":"Tyrosine kinase 2 is not limiting human antiviral type III interferon responses","volume":"46","author":"Fuchs","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.alit.2021.07.007_bib40","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s10875-019-00713-5","article-title":"A\u00a0new patient with inherited TYK2 deficiency","volume":"40","author":"Sarrafzadeh","year":"2020","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.alit.2021.07.007_bib41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000257290","article-title":"Ichthyosis linearis circumflexa","volume":"98","author":"Comel","year":"1949","journal-title":"Dermatologica"},{"key":"10.1016\/j.alit.2021.07.007_bib42","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/archderm.1958.01560100059009","article-title":"A\u00a0unique case of trichorrhexis nodosa; bamboo hairs","volume":"78","author":"Netherton","year":"1958","journal-title":"AMA Arch Derm"},{"key":"10.1016\/j.alit.2021.07.007_bib43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/75977","article-title":"Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome","volume":"25","author":"Chavanas","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.alit.2021.07.007_bib44","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaci.2009.06.009","article-title":"Comel-Netherton syndrome defined as primary immunodeficiency","volume":"124","author":"Renner","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.07.007_bib45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng1493","article-title":"Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity","volume":"37","author":"Descargues","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.alit.2021.07.007_bib46","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cellsig.2018.09.002","article-title":"TGF-beta receptors: in and beyond TGF-beta signaling","volume":"52","author":"Vander Ark","year":"2018","journal-title":"Cell Signal"},{"key":"10.1016\/j.alit.2021.07.007_bib47","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1056\/NEJMoa055695","article-title":"Aneurysm syndromes caused by mutations in the TGF-beta receptor","volume":"355","author":"Loeys","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2021.07.007_bib48","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1084\/jem.20120831","article-title":"Congenital B cell lymphocytosis explained by novel germline CARD11 mutations","volume":"209","author":"Snow","year":"2012","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.alit.2021.07.007_bib49","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaci.2015.03.008","article-title":"Mild B-cell lymphocytosis in patients with a CARD11 C49Y mutation","volume":"136","author":"Buchbinder","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.07.007_bib50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10875-014-0106-4","article-title":"Germline CARD11 mutation in a patient with severe congenital B cell lymphocytosis","volume":"35","author":"Brohl","year":"2015","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.alit.2021.07.007_bib51","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jaci.2013.02.012","article-title":"Whole-exome sequencing links caspase recruitment domain 11 (CARD11) inactivation to severe combined immunodeficiency","volume":"131","author":"Greil","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.07.007_bib52","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jaci.2012.11.050","article-title":"Deficiency of caspase recruitment domain family, member 11 (CARD11), causes profound combined immunodeficiency in human subjects","volume":"131","author":"Stepensky","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.07.007_bib53","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/ng.3898","article-title":"Germline hypomorphic CARD11 mutations in severe atopic disease","volume":"49","author":"Ma","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.alit.2021.07.007_bib54","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jaci.2017.06.047","article-title":"Combined immunodeficiency and atopy caused by a dominant negative mutation in caspase activation and recruitment domain family member 11 (CARD11)","volume":"141","author":"Dadi","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.07.007_bib55","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jaci.2018.08.013","article-title":"Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease","volume":"143","author":"Dorjbal","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893021000836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893021000836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:11:44Z","timestamp":1761156704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893021000836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1323893021000836"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2021.07.007","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyper-IgE syndrome, 2021 update","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2021.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Allergology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}